This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.
TREMFYA - Home
Last updated: 06/17/2025
TREMFYA® (guselkumab)
One-Press Patient-Controlled Injector
TREMFYA is approved for the treatment of adults with:
- Moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy.
- Active psoriatic arthritis.
- Moderately to severely active ulcerative colitis.
- Moderately to severely active Crohn’s disease.
This information is in supplement to the medication guide and instructions for Use. Prior to injection,
patients should be trained by their healthcare provider.
Overview
Important information about TREMFYA One-Press injector parts and storage conditions
Preparation
Summary of preparatory steps with regards to the supplies you will need and selecting an injection site before using TREMFYA One-Press injector
Injection
Stepwise illustration of using TREMFYA One-Press injector for administration
After injection
Recommendations for post-injection care and disposal